28 related articles for article (PubMed ID: 17419282)
1. mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study.
Kumar P; Sebastian A; Verma K; Dixit R; Kumari S; Singh J; Tiwary SK; Narayan G
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):85-92. PubMed ID: 33994733
[TBL] [Abstract][Full Text] [Related]
2. Role of extra cellular proteins in gastric cancer progression and metastasis: an update.
Abbaszadegan MR; Mojarrad M; Moghbeli M
Genes Environ; 2020; 42():18. PubMed ID: 32467737
[TBL] [Abstract][Full Text] [Related]
3. Global transcriptomic analysis identifies
Xu B; Bai Z; Yin J; Zhang Z
PeerJ; 2019; 7():e7091. PubMed ID: 31218131
[TBL] [Abstract][Full Text] [Related]
4. Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45.
Guo LY; Li YM; Qiao L; Liu T; Du YY; Zhang JQ; He WT; Zhao YX; He DQ
World J Gastroenterol; 2012 Dec; 18(48):7262-70. PubMed ID: 23326131
[TBL] [Abstract][Full Text] [Related]
5. Type IV collagen levels are elevated in the serum of patients with peritoneal dissemination of gastric cancer.
Kinoshita J; Fushida S; Harada S; Makino I; Nakamura K; Oyama K; Fujita H; Ninomiya I; Fujimura T; Kayahara M; Ohta T
Oncol Lett; 2010 Nov; 1(6):989-994. PubMed ID: 22870099
[TBL] [Abstract][Full Text] [Related]
6. [Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer].
Liu Z; Xu S; Xiao N; Song C; Zhang H; Li F
Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):795-802. PubMed ID: 20704821
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.
Sampieri CL; de la Peña S; Ochoa-Lara M; Zenteno-Cuevas R; León-Córdoba K
World J Gastroenterol; 2010 Mar; 16(12):1500-5. PubMed ID: 20333791
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer in the era of molecularly targeted agents: current drug development strategies.
Arkenau HT
J Cancer Res Clin Oncol; 2009 Jul; 135(7):855-66. PubMed ID: 19363621
[TBL] [Abstract][Full Text] [Related]
9. Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review.
Grunnet M; Mau-Sørensen M; Brünner N
Scand J Gastroenterol; 2013 Aug; 48(8):899-905. PubMed ID: 23834019
[TBL] [Abstract][Full Text] [Related]
10. Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression.
Hornebeck W; Lambert E; Petitfrère E; Bernard P
Biochimie; 2005; 87(3-4):377-83. PubMed ID: 15781325
[TBL] [Abstract][Full Text] [Related]
11. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma.
de Mingo M; Morán A; Sánchez-Pernaute A; Iniesta P; Díez-Valladares L; Pérez-Aguirre E; de Juan C; García-Aranda C; Díaz-López A; García-Botella A; Martín-Antona E; Benito M; Torres A; Balibrea JL
Hepatogastroenterology; 2007; 54(73):315-9. PubMed ID: 17419282
[TBL] [Abstract][Full Text] [Related]
12. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
[TBL] [Abstract][Full Text] [Related]
14. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
15. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
